Mike Poole is the co-founder for NeuShen. Most recently, Mike was a venture partner for Biomatics Capital, where he focused on identifying and evaluating investments in data- and genomics-enabled approaches for neuroscience and supported portfolio companies with transitional and operational leadership, leveraging his deep experience working with large pharma and venture-funded biotechnology companies.

Previously, Mike co-founded Neumora, a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience. He also led external investments in the office of the President for Global Health at the Bill and Melinda Gates Foundation. Prior to joining the Gates Foundation, he served as vice president and head of the Neuroscience Innovative Medicines group at AstraZeneca. Mike also served as chief medical officer for Link Medicine and Hypnion, and was vice president of neuroscience development at Wyeth and Pfizer.

Mike is board certified in internal medicine, having trained at Strong Memorial Hospital at the University of Rochester. He also is board-certified in adult neurology, completing his postgraduate training in neurology at the University of Michigan. Mike holds an undergraduate degree from the University of California, Berkeley and an M.D. from the UC San Diego School of Medicine.